InsiderTrades

Form 4 for LEGN Legend Biotech Corp

Accepted 2026-09-23 16:15:08 ET · period of report 2026-09-21 · accession 0002097065-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-09-23 16:15 2026-09-21 LEGN Santos Carlos E CFO A - Grant $0.00 +19.7K 19.7K New $0
2026-09-23 16:15 2026-09-21 LEGN Santos Carlos E CFO S - Sale $9.14 -5,430 14.2K -28% -$49.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2026-09-21 A A 19,676 $0.00 19,676 D — — (F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
2 Common Ordinary Shares 2026-09-21 S D 5,430 $9.14 14,246 D — — (F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. (F2) Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units. (F3) The price reported in Column 4 is a weighted average price. The prices sold ranged from $8.905 to $9.325 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.